You can’t benchmark our medicines funding against other countries’ without also scrutinising Pharmac’s fixed budget, argues Cancer Society medical director Chris Jackson
Medicines New Zealand, the industry association representing companies involved in the research, development and manufacture of modern medicines and vaccines, is supportive of the proposed review into PHARMAC if it is intended to improve the existing system and enhance modern medicines access for patients and the health system
The Government is following through on an election promise to conduct an independent review into PHARMAC, Prime Minister Jacinda Ardern and Health Minister Andrew Little announced today
The chair of Pharmac’s Pharmacology and Therapeutics Advisory Committee was grilled today over the body’s approach to assessing whether a controversial drug-funding switch should have taken place
In painstaking detail today, Pharmac outlined steps taken to manage a controversial anti-epilepsy drug-funding switch, while a UK epilepsy advocate offered the coronial inquest an alternative approach
Communication between people with epilepsy, their doctors and between agencies, around the potential risks of switching brands of anti-epileptic lamotrigine was examined at today’s epilepsy deaths inquest
Pharmac has eased access to highly regarded new type 2 diabetes drugs for Māori and Pacific patients, by requiring they meet only one Special Authority criterion
Specialist GP Nikki Vadgama provides some tips to make your next paediatric eczema consult easier. She includes a review of new guidelines, resources, websites and medications for paediatric eczema management